The Regenerative Medicine Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Growing number of Joint Ventures to fuel market growth
The demand for breakthrough techniques in tissue engineering, cell therapy, and stem cell use is increasing due to the rising prevalence of chronic diseases and clinical trials. Continuous joint ventures, mergers, acquisitions, and other strategic activity by various companies is helping the regenerative medicine market thrive. For instance, in October 2022, Dr. Vanessa Rodriguez Pares and Meso Numismatics, Inc. (MSSV), a biotech and numismatics-focused technology company, partnered with the new STEM LIFE clinic facility. This collaboration aims to promote regenerative medicine’s high standards. Similar to this, Astellas Pharma Inc. and Pantherna Therapeutics GmbH entered into a technology evaluation agreement in October 2022 to carry out research to create mRNA-based regenerative medicine programmes employing direct reprogramming (trans-differentiation). Additionally, in October 2020, the world’s largest pharmaceutical corporation Bayer bought Asklepios BioPharmaceutical, a gene therapy business with operations in San Sebastián, Spain, Edinburgh, and Paris, in a deal valued at up to US$ 4 billion. Such actions significantly influence the market for regenerative medicine’s growth pace.
Product Recalls may hamper the market growth
Regenerative medicine is a speedily evolving field and involves the use of wide array of techniques to repair or replace damaged tissues and organs. With the increasing popularity and use of these products, there have been instances of product recalls in the regenerative medicine market. The growth of the regenerative medicine market can be impeded owing to the increasing number of product recalls. Biotech companies continue to face difficulties such as risk of product recalls and marketing their genetic medicine in the market. For instance, Bluebird Bio, a US-based gene therapy company, withdrew its gene therapy for a rare blood disorder from the German market in April 2021 after failing to reach an agreement on the treatment’s cost with German health authorities. This recall impacted the company’s sales and brand image. Similarly, small-scale companies are severely affected as they fail to recover from losses due to product recalls because they operate without robust cash flow and brand recognition.
What Questions Should You Ask before Buying a Market Research Report?
• How is the Regenerative Medicine Market evolving?
• What is driving and restraining the Regenerative Medicine Market?
• How will each Regenerative Medicine submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Regenerative Medicine submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Regenerative Medicine Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Regenerative Medicine development projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Regenerative Medicine development projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Regenerative Medicine Market?
• Where is the Regenerative Medicine Market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Regenerative Medicine Market today, and over the next 10 years:
• Our 232-page report provides 101 tables and 108 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Regenerative Medicine Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising prices of regenerative medicines and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Product
• Stem Cell Therapy
– Autologous
– Allogenic
• Tissue Engineering
– Scaffold
– Hydrogels
• Gene Therapy
• Others
By Application
• Regenerative Medicine
– Oncology
– Dermatology
– Musculoskeletal
– Neurology
– Cardiovascular
– Wound Healing
– Ophthalmology
– Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America Latin America
MEA
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Regenerative Medicine Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Amgen
• Anterogen
• Avita Medical Inc.
• Bio Solutions. Co. Ltd
• Bluebird Bio Inc.
• Bristol Myers Squibb
• Gilead Sciences, Inc.
• Integra Life Sciences
• Misoblast Ltd
• Novartis AG
• Organogenesis Inc.
• Sarepta Therapeutics,Inc
• Sibino GeneTech Co. Ltd
• Smith & Nephew plc
• Terumo BCT
Overall world revenue for Regenerative Medicine Market, 2023 to 2033 in terms of value the market will surpass US$ 59.15 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Regenerative Medicine Market, 2023 to 2033 report help you?
In summary, our 232-page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Regenerative Medicine Market, 2023 to 2033 Market, with forecasts for Type of Product and Application at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Regenerative Medicine Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Regenerative Medicine Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Regenerative Medicine Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Regenerative Medicine Market Report 2023-2033: Forecasts by Product (Cell Therapy (Autologous, Allogenic), Tissue Engineering (Scaffold, Hydrogels), Gene Therapy, Others), by Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Regenerative Medicine Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Strategic Activities and Collaborations
3.2.1.2 Rise in Research and Development Projects
3.2.1.3 Surging Government Support
3.2.2 Market Restraining Factors
3.2.2.1 Substantial Number of Product Recalls
3.2.2.2 Unapproved Products in the Market
3.2.3 Market Opportunities
3.2.3.1 Growing Research Partnership in Developed and Developing Countries across the globe
3.2.3.2 Growing awareness about the advances in medical research
3.2.3.3 Growing Investment and Funding
3.2.4 .COVID-19 Impact Analysis
3.3 Porter’s Five Forces Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Competitive Rivalry
3.3.4 Threat from Substitutes
3.3.5 Threat of New Entrants
3.4 PEST Analysis
4 Regenerative Medicine Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Regenerative Medicine Market Size Estimation and Forecast by Product
4.4 Stem Cell Therapy
4.4.1 Regenerative Medicine Market Forecast by Stem Cell Therapy, 2023-2033 (US$ Bn)
4.4.1.1 Market Size by Region, 2023-2033 (US$ Bn)
4.4.1.2 Market Share by Region, 2023 & 2033 (%)
4.5 Tissue Engineering
4.5.1.1 Regenerative Medicine Market Forecast by Tissue Engineering, 2023-2033 (US$ Bn)
4.5.1.2 Market Size by Region, 2023-2033 (US$ Bn)
4.5.1.3 Market Share by Region, 2023 & 2033 (%)
4.6 Gene Therapy
4.6.1.1 Market Size by Region, 2023-2033 (US$ Bn)
4.6.1.2 Market Share by Region, 2023 & 2033 (%)
4.7 Others
4.7.1.1 Market Size by Region, 2023-2033 (US$ Bn)
4.7.1.2 Market Share by Region, 2023 & 2033 (%)
5 Regenerative Medicine Market Analysis by Application
5.1 Key Findings
5.2 Product Segment: Market Attractiveness Index
5.3 Regenerative Medicine Market Size Estimation and Forecast by Application
5.4 Oncology
5.4.1 Market Size by Region, 2023-2033 (US$ Bn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Dermatology
5.5.1 Market Size by Region, 2023-2033 (US$ Bn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Musculoskeletal
5.6.1 Market Size by Region, 2023-2033 (US$ Bn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Neurology
5.7.1 Market Size by Region, 2023-2033 (US$ Bn)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Cardiovascular
5.8.1 Market Size by Region, 2023-2033 (US$ Bn)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Wound Healing
5.9.1 Market Size by Region, 2023-2033 (US$ Bn)
5.9.2 Market Share by Region, 2023 & 2033 (%)
5.10 Ophthalmology
5.10.1 Market Size by Region, 2023-2033 (US$ Bn)
5.10.2 Market Share by Region, 2023 & 2033 (%)
5.11 Others
5.11.1 Market Size by Region, 2023-2033 (US$ Bn)
5.11.2 Market Share by Region, 2023 & 2033 (%)
6 Regenerative Medicine Market Analysis by Region
6.1 Key Findings
6.2 Regional Segment: Market Attractiveness Index
6.3 Regenerative Medicine Market Size Estimation and Forecast
7 North America Regenerative Medicine Market Analysis
7.1 Key Findings
7.2 North America Regenerative Medicine Market Attractiveness Index
7.3 North America Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ Bn)
7.4 North America Regenerative Medicine Market Size Estimation and Forecast by Country
7.5 North America Regenerative Medicine Market Size Estimation and Forecast by Product
7.6 North America Regenerative Medicine Market Size Estimation and Forecast by Application
7.7 U.S. Regenerative Medicine Market Analysis
7.8 Canada Regenerative Medicine Market Analysis
8 Europe Regenerative Medicine Market Analysis
8.1 Key Findings
8.2 Europe Regenerative Medicine Market Attractiveness Index
8.3 Europe Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ Bn)
8.4 Europe Regenerative Medicine Market Size Estimation and Forecast by Country
8.5 Europe Regenerative Medicine Market Size Estimation and Forecast by Product
8.6 Europe Regenerative Medicine Market Size Estimation and Forecast by Application
8.7 Germany Regenerative Medicine Market Analysis
8.8 France Regenerative Medicine Market Analysis
8.9 UK Regenerative Medicine Market Analysis
8.10 Italy Regenerative Medicine Market Analysis
8.11 Spain Regenerative Medicine Market Analysis
8.12 Russia Regenerative Medicine Market Analysis
8.13 Rest of Europe Regenerative Medicine Market Analysis
9 Asia Pacific Regenerative Medicine Market Analysis
9.1 Key Findings
9.2 Asia Pacific Regenerative Medicine Market Attractiveness Index
9.3 Asia Pacific Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ Bn)
9.4 Asia Pacific Regenerative Medicine Market Size Estimation and Forecast by Country
9.5 Asia Pacific Regenerative Medicine Market Size Estimation and Forecast by Product
9.6 Asia Pacific Regenerative Medicine Market Size Estimation and Forecast by Application
9.7 Japan Regenerative Medicine Market Analysis
9.8 China Regenerative Medicine Market Analysis
9.9 India Regenerative Medicine Market Analysis
9.10 Australia Regenerative Medicine Market Analysis
9.11 South Korea Regenerative Medicine Market Analysis
9.12 Rest of Asia Pacific Regenerative Medicine Market Analysis
10 Latin America Regenerative Medicine Market Analysis
10.1 Key Findings
10.2 Latin America Regenerative Medicine Market Attractiveness Index
10.3 Latin America Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ Bn)
10.4 Latin America Regenerative Medicine Market Size Estimation and Forecast by Country
10.5 Latin America Regenerative Medicine Market Size Estimation and Forecast by Product
10.6 Latin America Regenerative Medicine Market Size Estimation and Forecast by Application
10.7 Brazil Regenerative Medicine Market Analysis
10.8 Mexico Regenerative Medicine Market Analysis
10.9 Rest of Latin America Regenerative Medicine Market Analysis
11 MEA Regenerative Medicine Market Analysis
11.1 Key Findings
11.2 MEA Regenerative Medicine Market Attractiveness Index
11.3 MEA Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ Bn)
11.4 MEA Regenerative Medicine Market Size Estimation and Forecast by Country
11.5 MEA Regenerative Medicine Market Size Estimation and Forecast by Product
11.6 MEA Regenerative Medicine Market Size Estimation and Forecast by Application
11.7 GCC Regenerative Medicine Market Analysis
11.8 South Africa Regenerative Medicine Market Analysis
11.9 Rest of MEA Regenerative Medicine Market Analysis
12 Company Profiles
12.1 Company share analysis, 2021
12.2 Amgen
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Financial Analysis
12.2.3.1 Net Revenue, 2017-2021
12.2.3.2 R&D, 2017-2021
12.2.3.3 Regional Market Shares, 2021
12.2.4 Product Benchmarking
12.2.5 Strategic Outlook
12.3 Anterogen
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Net Revenue, 2017-2021
12.3.3.2 R&D, 2017-2021
12.3.4 Product Benchmarking
12.4 Avita Medical, Inc.
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2017-2021
12.4.3.2 R&D, 2017-2021
12.4.3.3 Regional Market Shares, 2021
12.4.4 Product Benchmarking
12.4.5 Strategic Outlook
12.5 Bio Solution Co. Ltd.
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2017-2021
12.5.4 Product Benchmarking
12.5.5 Strategic Outlook
12.6 Bluebird Bio, Inc.
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2017-2021
12.6.3.2 R&D, 2017-2021
12.6.4 Product Benchmarking
12.6.5 Strategic Outlook
12.7 Bristol Myers Squibb
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2017-2022
12.7.3.2 R&D, 2017-2022
12.7.3.3 Regional Market Shares, 2022
12.7.4 Product Benchmarking
12.7.5 Strategic Outlook
12.8 Gilead Sciences, Inc.
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2017-2022
12.8.3.2 R&D, 2017-2021
12.8.3.3 Regional Market Shares, 2022
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Integra LifeSciences
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Financial Analysis
12.9.3.1 Net Revenue, 2017-2021
12.9.3.2 R&D, 2017-2021
12.9.3.3 Regional Market Shares, 2021
12.9.4 Product Benchmarking
12.9.5 Strategic Outlook
12.10 Mesoblast Ltd
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Financial Analysis
12.10.3.1 Net Revenue, 2017-2022
12.10.3.2 R&D, 2017-2021
12.10.4 Product Benchmarking
12.10.5 Strategic Outlook
12.11 Novartis AG
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2022
12.11.3.2 R&D, 2017-2022
12.11.3.3 Regional Market Shares, 2022
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Organogenesis Inc.
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Financial Analysis
12.12.3.1 Net Revenue, 2017-2021
12.12.3.2 R&D, 2017-2021
12.12.4 Product Benchmarking
12.12.5 Strategic Outlook
12.13 Sarepta Therapeutics, Inc.
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Financial Analysis
12.13.3.1 Net Revenue, 2017-2021
12.13.3.2 R&D, 2017-2021
12.13.4 Product Benchmarking
12.13.5 Strategic Outlook
12.14 Sibiono GeneTech Co. Ltd
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Product Benchmarking
12.15 Smith & Nephew plc
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Financial Analysis
12.15.3.1 Net Revenue, 2017-2021
12.15.3.2 R&D, 2017-2021
12.15.3.3 Regional Market Shares, 2021
12.15.4 Product Benchmarking
12.15.5 Strategic Outlook
12.16 Terumo BCT
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Financial Analysis
12.16.3.1 Net Revenue, 2017-2021
12.16.3.2 R&D, 2017-2021
12.16.3.3 Regional Market Shares, 2021
12.16.4 Product Benchmarking
12.16.5 Strategic Outlook
13 Conclusion and Recommendations
13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players
List of Tables
Table 1 Regenerative Medicine Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
Table 2 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 7 Regenerative Medicine Market Forecast by Stem Cell Therapy, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 8 Stem Cell Therapy Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 9 Regenerative Medicine Market Forecast by Tissue Engineering, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 10 Tissue Engineering Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 11 Gene Therapy Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 12 Others Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 13 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 14 Oncology Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 15 Dermatology Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 16 Musculoskeletal Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 17 Neurology Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 18 Cardiovascular Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 19 Wound Healing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 20 Ophthalmology Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 21 Others Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 22 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 23 North America Regenerative Medicine Market Forecast by Country 2023-2033 (US$ bn, AGR%, CAGR %)
Table 24 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 25 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 26 U.S. Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR %, CAGR %)
Table 27 Canada Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR %, CAGR %)
Table 28 Europe Regenerative Medicine Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 29 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 30 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 31 Germany Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 32 France Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 33 UK Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 34 Italy Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 35 Spain Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 36 Russia Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 37 Rest of Europe Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 38 Asia Pacific Regenerative Medicine Market forecast by Country 2023-2033 (US$ bn, AGR%, CAGR %)
Table 39 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 40 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 41 Japan Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Table 42 China Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 43 India Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 44 Australia Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 45 South Korea Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Table 46 Rest of Asia Pacific Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 47 Latin America Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 48 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 49 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ bn, AGR (%), CAGR (%))
Table 50 Brazil Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 51 Mexico Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 52 Rest of Latin America Regenerative Drugs Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 53 MEA Regenerative Drugs forecast by Country 2023-2033 (US$ bn, AGR%, CAGR %)
Table 54 Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
Table 55 Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
Table 56 GCC Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 57 South Africa Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 58 Rest of MEA Regenerative Medicine Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR %)
Table 59 Amgen : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 60 Amgen : Product Benchmarking
Table 61 Amgen : Strategic Outlook
Table 62 Anterogen : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Anterogen : Product Benchmarking
Table 64 Avita Medical, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 65 Avita Medical , Inc. : Product Benchmarking
Table 66 Avita Medical , Inc. : Strategic Outlook
Table 67 Bio Solution Co. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 68 Bio Solution Co. Ltd .: Product Benchmarking
Table 69 Bio Solution Co. Ltd .: Strategic Outlook
Table 70 Bluebird Bio, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 Bluebird Bio, Inc.: Product Benchmarking
Table 72 Bluebird Bio, Inc.: Strategic Outlook
Table 73 Bristol Myers Squibb : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Bristol Myers Squibb : Product Benchmarking
Table 75 Bristol Myers Squibb : Strategic Outlook
Table 76 Gilead Sciences, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Gilead Sciences, Inc. : Product Benchmarking
Table 78 Gilead Science, Inc. : Strategic Outlook
Table 79 Integra LifeSciences :(CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Integra LifeSciences : Product Benchmarking
Table 81 Integra LifeSciences .: Strategic Outlook
Table 82 Mesoblast Ltd : (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Mesoblast Ltd : Product Benchmarking
Table 84 Mesoblast Ltd .: Strategic Outlook
Table 85 Novartis AG ,: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Novartis AG: : Product Benchmarking
Table 87 Novartis AG: .: Strategic Outlook
Table 88 Organogenesis Inc. :(CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Organogenesis Inc. : Product Benchmarking
Table 90 Organogenesis Inc.: Strategic Outlook
Table 91 Sarepta Therapeutics, Inc. :(CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Sarepta Therapeutics, Inc.: Product Benchmarking
Table 93 Sarepta Therapeutics, Inc..: Strategic Outlook
Table 94 Sibiono GeneTech Co. Ltd :(CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Sibiono GeneTech Co. Ltd : Product Benchmarking
Table 96 Smith & Nephew plc,: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Smith & Nephew: : Product Benchmarking
Table 98 Smith & Nephew: .: Strategic Outlook
Table 99 Terumo BCT,: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Terumo BCT: : Product Benchmarking
Table 101 Terumo BCT: .: Strategic Outlook
List of Figures
Figure 1 Regenerative Medicine Market Segmentation
Figure 2 Regenerative Medicine Market by Product: Market Attractiveness Index
Figure 3 Regenerative Medicine Market Attractiveness Index by Application
Figure 4 Regenerative Medicine Market Attractiveness Index by Region
Figure 5 Regenerative Medicine Market: Market Dynamics
Figure 6 COVID Impact Analysis: Regenerative Medicine Market Recovery Scenarios
Figure 7 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 8 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 9 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 10 Regenerative Medicine Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 11 Regenerative Medicine Market: Porter’s Five Forces Analysis
Figure 12 Regenerative Medicine Market: PEST Analysis
Figure 13 Regenerative Medicine Market by Product: Market Attractiveness Index
Figure 14 Regenerative Medicine Market Forecast by Product , 2023-2033 (US$ billion)
Figure 15 Regenerative Medicine Market Share Forecast by Product, 2023-2033 (%)
Figure 16 Stem Cell Therapy Market Forecast by Region, 2023-2033 (US$ billion)
Figure 17 Stem Cell Therapy Market Share Forecast by Region, 2023 & 2033 (%)
Figure 18 Tissue Engineering Market Forecast by Region, 2023-2033 (US$ billion)
Figure 19 Tissue Engineering Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Gene Therapy Market Forecast by Region, 2023-2033 (US$ billion)
Figure 21 Gene Therapy Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 Others Market Forecast by Region, 2023-2033 (US$ billion)
Figure 23 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 Regenerative Medicine Market by Application: Market Attractiveness Index
Figure 25 Regenerative Medicine Market Forecast by Application , 2023-2033 (US$ billion)
Figure 26 Regenerative Medicine Market Share Forecast by Application, 2023-2033 (%)
Figure 27 Oncology Market Forecast by Region, 2023-2033 (US$ billion)
Figure 28 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Dermatology Market Forecast by Region, 2023-2033 (US$ billion)
Figure 30 Dermatology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Musculoskeletal Market Forecast by Region, 2023-2033 (US$ billion)
Figure 32 Musculoskeletal Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 Neurology Market Forecast by Region, 2023-2033 (US$ billion)
Figure 34 Neurology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 1 Cardiovascular Market Forecast by Region, 2023-2033 (US$ billion)
Figure 2 Cardiovascular Market Share Forecast by Region, 2023 & 2033 (%)
Figure 3 Wound Healing Market Forecast by Region, 2023-2033 (US$ billion)
Figure 4 Wound Healing Market Share Forecast by Region, 2023 & 2033 (%)
Figure 5 Ophthalmology Market Forecast by Region, 2023-2033 (US$ billion)
Figure 6 Ophthalmology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 7 Others Market Forecast by Region, 2023-2033 (US$ billion)
Figure 8 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 9 Regenerative Medicine Market by Region: Market Attractiveness Index
Figure 10 Regenerative Medicine Market by Region, 2023-2033 (US$ bn)
Figure 11 Regenerative Medicine Market Share Forecast by Region 2023, 2033(%)
Figure 12 North America Regenerative Medicine Market Attractiveness Index
Figure 13 North America Regenerative Medicine Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 14 North America Regenerative Medicine Market Forecast by Country, 2023-2033 (US$ billion)
Figure 15 North America Regenerative Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 16 North America Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ billion)
Figure 17 North America Regenerative Medicine Market Share Forecast by Product, 2023 & 2033 (%)
Figure 18 North America Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ billion)
Figure 19 North America Regenerative Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 20 U.S. Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 21 Canada Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 22 Europe Regenerative Medicine Market Attractiveness Index
Figure 23 Europe Regenerative Medicine Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 24 Europe Regenerative Medicine Market Forecast by Country, 2023-2033 (US$ billion)
Figure 25 Europe Regenerative Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 26 Europe Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ billion)
Figure 27 Europe Regenerative Medicine Market Share Forecast by Product, 2023 & 2033 (%)
Figure 28 Europe Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ billion)
Figure 29 Europe Regenerative Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 30 Germany Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 31 France Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 32 UK Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 33 Italy Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 34 Spain Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 35 Russia Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 36 Rest of Europe Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 37 Asia Pacific Regenerative Medicine Market Attractiveness Index
Figure 38 Asia Pacific Regenerative Medicine Market by Region, 2023, 2028 & 2033 (US$ billion)
Figure 39 Asia Pacific Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 40 Asia Pacific Regenerative Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 41 Asia Pacific Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ billion)
Figure 42 Asia Pacific Regenerative Medicine Market Share Forecast by Product, 2023 & 2033 (%)
Figure 43 Asia Pacific Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ billion)
Figure 44 Asia Pacific Regenerative Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 45 Japan Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 46 China Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 47 India Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 48 Australia Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 49 South Korea Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 50 Rest of Asia Pacific Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 51 Latin America Regenerative Medicine Market Attractiveness Index
Figure 52 Latin America Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ billion)
Figure 53 Latin America Regenerative Medicine Market Forecast by Country, 2023-2033 (US$ billion)
Figure 54 Latin America Regenerative Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 55 Latin America Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ billion)
Figure 56 Latin America Regenerative Medicine Market Share Forecast by Product, 2023 & 2033 (%)
Figure 57 Latin America Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ billion)
Figure 58 Latin America Regenerative Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 59 Brazil Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 60 Mexico Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 61 Rest of Latin America Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 62 MEA Regenerative Medicine Market Attractiveness Index
Figure 63 MEA Regenerative Medicine Market by Country, 2023, 2028 & 2033 (US$ billion)
Figure 64 MEA Regenerative Medicine Market Forecast by Country, 2023-2033 (US$ billion)
Figure 65 MEA Regenerative Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 66 MEA Regenerative Medicine Market Forecast by Product, 2023-2033 (US$ billion)
Figure 67 MEA Regenerative Medicine Market Share Forecast by Product, 2023 & 2033 (%)
Figure 68 MEA Regenerative Medicine Market Forecast by Application, 2023-2033 (US$ billion)
Figure 69 MEA Regenerative Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 70 GCC Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 71 South Africa Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 72 Rest of MEA Regenerative Medicine Market Forecast, 2023-2033 (US$ billion, AGR %)
Figure 73 Company Share Analysis, 2021
Figure 74 Amgen; Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 75 Amgen; R&D, 2017-2021 (US$ million, AGR %)
Figure 76 Amgen: Regional Market Shares, 2021
Figure 77 Anterogen; Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 78 Anterogen; R&D, 2017-2021 (US$ million, AGR %)
Figure 79 Avita Medical Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 80 Avita Medical, Inc.: R&D, 2017-2021 (US$ million, AGR %)
Figure 81 Avita Medical , Inc.: Regional Market Shares, 2021
Figure 82 Bio Solution Co. Ltd: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 83 Bluebird Bio, Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 84 Bluebird Bio, Inc.: R&D, 2017-2021 (US$ million, AGR %)
Figure 85 Bristol Myers Squibb: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 86 Bristol Myers Squibb; R&D, 2017-2022 (US$ million, AGR %)
Figure 87 Bristol Myers Squibb: Regional Market Shares, 2022
Figure 88 Gilead Sciences, Inc.: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 89 Gilead Sciences, Inc.: R&D, 2017-2022 (US$ million, AGR %)
Figure 90 Gilead Sciences, Inc.: Regional Market Shares, 2022
Figure 91 Integra LifeSciences.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 92 Integra LifeSciences.: R&D, 2017-2021 (US$ million, AGR %)
Figure 93 Integra LifeSciences: Regional Market Shares, 2021
Figure 94 Mesoblast Ltd.: Net Revenue, 2017-2022 (US$ million, AGR %)
Figure 95 Mesoblast Ltd.: R&D, 2017-2021 (US$ million, AGR %)
Figure 96 Novartis AG: Net Revenue, 2017-2022 (US$ million, AGR %)
Figure 97 Novartis AG: R&D, 2017-2022 (US$ million, AGR %)
Figure 98 Novartis AG:: Regional Market Shares, 2022
Figure 99 Organogenesis Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 100 Organogenesis Inc.: R&D, 2017-2021 (US$ million, AGR %)
Figure 101 Sarepta Therapeutics, Inc..: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 102 Sarepta Therapeutics, Inc.: R&D, 2017-2021 (US$ million, AGR %)
Figure 103 Smith & Nephew: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 104 Smith & Nephew:; R&D, 2017-2021 (US$ million, AGR%)
Figure 105 Smith & Nephew:: Regional Market Shares, 2021
Figure 106 Terumo BCT: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 107 Terumo BCT: R&D, 2017-2021 (US$ million, AGR %)
Figure 108 Terumo BCT:: Regional Market Shares, 2021
List of Companies Profiled in the Report
Amgen
Anterogen
Avita Medical Inc.
Bio Solutions. Co. Ltd
Bluebird Bio Inc.
Bristol Myers Squibb
Gilead Sciences, Inc.
Integra Life Sciences
Misoblast Ltd
Novartis AG
Organogenesis Inc.
Sarepta Therapeutics,Inc
Sibino GeneTech Co. Ltd
Smith & Nephew plc
Terumo BCT
List of Other Companies Mentioned in the Report
Alia Therapeutics
Asklepios BioPharmaceutical
Astellas Pharma Inc.
AusBiotech
Bayer AG,
BioCardia, Inc.
Biointelect Pty Ltd
BioLife Solutions
Borea Therapeutics
BrainVectis
Cell Therapies Pty Ltd
Collagen Matrix, Inc.
Crown Aesthetics
Dimension Inx
Emergent Health Corp
Epsilen Bio
EVOLVE Medical Inc.
GAIA BioMedicine
Genespire
IASO Biotherapeutics
JCR Pharmaceuticals Co., Ltd
LABS, INC
Lineage Cell Therapeutics, Inc.
Medicines Australia
Nanosthetic Corp.
Pantherna Therapeutics GmbH
Pfizer
PinCell
Polyganics, B.V
Regenerative Health Space
Research Strategies Australia
Sofinnova
SYMX
Sysmex Corporation
TaiMed Biologics
WEP Clinical LTD
List of Associations Mentioned in the Report
American Cancer Society
Canadian Stem Cell Network (SCN)
Canadian Stem Cell Network (SCN)
Cell and Gene Therapy Catapult
Department of Biotechnology (DBT
Egypt Center for Research and Regenerative Medicine (ECRRM
Egypt Center for Research and Regenerative Medicine (ECRRM)
European Association for the Study of the Liver (EASL
Food and Drug Administration
International Human Frontier Science Program (HFSP).
International Liver Congress (ILC)
International Stem Cell and Regenerative Medicine Research and Therapeutic Centre
Japan Agency for Medical Research and Development (AMED
Japan Agency for Medical Research and Development (AMED)
Medical Research Council (MRC
Medical Research Council (MRC
Meso Numismatics, Inc. (MSSV)
Ministry of Food and Drug Safety (MFDS), South Korea
National Agency for Safety of Medicines and Health Products (ANSM)
National Agency for Safety of Medicines and Health Products (ANSM),
National Institutes of Health (NIH)
National Science Foundation (NSF)
Regenerative Medicine Advanced Therapy (RMAT)
STEM LIFE clinic facility
The American Cancer Society
UK Regenerative Medicine Platform (UKRMP
UK Regenerative Medicine Platform (UKRMP)
University Health Network (UHN)
University Health Network (UHN),
University Health Network and Aspect Biosystems
U.S. Food and Drug Administration (U.S.FDA)
Venezuelan Institute of Scientific Research's (IVIC)
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
